{"id":6992,"date":"2020-08-19T05:05:37","date_gmt":"2020-08-19T10:05:37","guid":{"rendered":"http:\/\/esterlund.com\/blog\/?p=6992"},"modified":"2020-08-19T05:05:37","modified_gmt":"2020-08-19T10:05:37","slug":"read-the-fine-print-part-two-nearly-400-adverse-reactions-listed-in-vaccine-package-inserts-naturalnews-com","status":"publish","type":"post","link":"https:\/\/esterlund.com\/blog\/read-the-fine-print-part-two-nearly-400-adverse-reactions-listed-in-vaccine-package-inserts-naturalnews-com\/","title":{"rendered":"Read the fine print, part two \u2013 Nearly 400 adverse reactions listed in vaccine package inserts \u2013 NaturalNews.com"},"content":{"rendered":"

\"Image:<\/p>\n

Source: Read the fine print, part two \u2013 Nearly 400 adverse reactions listed in vaccine package inserts \u2013 NaturalNews.com<\/a><\/em><\/p>\n

(Natural News<\/a>) Package inserts are available online for\u00a0all vaccines<\/a>\u00a0licensed in the U.S. In addition to containing bits of practical information for the clinicians who administer the vaccines, the inserts provide members of the public with one of their only opportunities to learn about a vaccine\u2019s contraindications, warnings, precautions and\u2014perhaps most importantly\u2014potential adverse reactions.<\/p>\n

(Article republished from\u00a0ChildrensHealthDefense.org<\/a>)<\/p>\n

The inserts communicate the information about adverse reactions in two distinct sections: \u201cClinical trials experience\u201d (Section 6.1) and \u201cData from postmarketing experience\u201d from the U.S. or other countries (Section 6.2). In April, 2020, Children\u2019s Health Defense summarized the\u00a0postmarketing data<\/a>\u00a0for over three dozen vaccines given routinely to American infants, children and adolescents. That tally showed that vaccines touted for the prevention of 13 illnesses (Table 1) have been linked to at least 217 adverse medical outcomes reported post-licensure, including serious infections, autoimmune conditions, life-threatening allergies and death.<\/p>\n

Table 1. Vaccine package inserts reviewed<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Type
\nof Vaccine<\/h4>\n<\/td>\n

\n

Brand Name<\/h4>\n<\/td>\n

\n

Manufacturer<\/h4>\n<\/td>\n<\/tr>\n

Vaccines containing
\ndiphtheria, tetanus and pertussis components<\/td>\n		Adacel (Tdap)<\/a><\/td>\nSanofi Pasteur<\/td>\n<\/tr>\n
Boostrix (Tdap)<\/a><\/td>\nGlaxoSmithKline
\n(GSK)<\/td>\n<\/tr>\n
Daptacel (DTaP)<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Diphtheria
\nand Tetanus Toxoids Adsorbed (DT)<\/a><\/td>\n		Sanofi<\/td>\n<\/tr>\n
Infanrix (DTaP)<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Kinrix (DTaP-IPV)<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Pediarix (DTaP-HepB-IPV)<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Pentacel (DTaP-IPV\/Hib)<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Quadracel (DTaP-IPV)<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Tdvax (Td)<\/a><\/td>\nMassBiologics<\/td>\n<\/tr>\n
Tenivac (Td)<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Haemophilus
\ninfluenzae type b (Hib)<\/td>\n		ActHIB<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Hiberix<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
PedvaxHIB<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Hepatitis A and\/or B<\/td>\nEngerix-B (HepB)<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Havrix (HepA)<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Recombivax HB (HepB)<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Twinrix (HepA\/HepB)<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Vaqta (HepA)<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Human papillomavirus (HPV)<\/td>\nGardasil<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Gardasil 9<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Influenza<\/td>\nAfluria Quadrivalent<\/a><\/td>\nSequirus<\/td>\n<\/tr>\n
Fluarix<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Flublok
\nQuadrivalent (age 18 and older)<\/a><\/td>\n		Protein Sciences
\nCorporation<\/td>\n<\/tr>\n
Flucelvax<\/a><\/td>\nSequirus<\/td>\n<\/tr>\n
Flulaval Quadrivalent<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
FluMist<\/a><\/td>\nAstraZeneca<\/td>\n<\/tr>\n
Fluzone Quadrivalent<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Meningococcal A, C, W and\/or Y<\/td>\nMenactra<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Menomune<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Menveo<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Meningococcal B<\/td>\nBexero<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
Trumenba<\/a><\/td>\nPfizer<\/td>\n<\/tr>\n
Measles-mumps-rubella
\n(MMR) and MMR+varicella (MMRV)<\/td>\n		MMR-II<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Proquad<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Pneumococcal<\/td>\nPrevnar-13<\/a><\/td>\nPfizer<\/td>\n<\/tr>\n
Pneumovax-23<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Inactivated polio (IPV)<\/td>\nIPOL<\/a><\/td>\nSanofi<\/td>\n<\/tr>\n
Rotavirus vaccines<\/td>\nRotarix<\/a><\/td>\nGSK<\/td>\n<\/tr>\n
RotaTeq<\/a><\/td>\nMerck<\/td>\n<\/tr>\n
Varicella<\/td>\nVarivax<\/a><\/td>\nMerck<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Source: Read the fine print, part two \u2013 Nearly 400 adverse reactions listed in vaccine package inserts \u2013 NaturalNews.com (Natural News) Package inserts are available online for\u00a0all vaccines\u00a0licensed in the U.S. In addition to containing bits of practical information for the clinicians who administer the vaccines, the inserts provide members of the public with one … Continue reading Read the fine print, part two \u2013 Nearly 400 adverse reactions listed in vaccine package inserts \u2013 NaturalNews.com<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[4,29],"tags":[],"_links":{"self":[{"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/posts\/6992"}],"collection":[{"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/comments?post=6992"}],"version-history":[{"count":1,"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/posts\/6992\/revisions"}],"predecessor-version":[{"id":6994,"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/posts\/6992\/revisions\/6994"}],"wp:attachment":[{"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/media?parent=6992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/categories?post=6992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/esterlund.com\/blog\/wp-json\/wp\/v2\/tags?post=6992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}